ArticleMedical hypotheses2022

COVID-19 diverse outcomes: Aggravated reinfection, type I interferons and antibodies.

Rafael Cardoso Maciel Costa Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.